A4W4F3 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifs2366riqqfmjukmr3nx4ufkv5rv5rotemzeqvvwcv263ykspibu/metadata.json
IPFS of structure file: 
bafybeie34sq7l7s4z74fawtuf3lbnimk2lq33oypml4rgbsnjqzg4w73fu/AF-A4W4F3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xC0C15E77571eb492a29A53B44C2DeEE0B49693cb
First NFT owner address (bech32): 
genesis1crq4ua6hr66f9g562w6yct0wuz6fdy7tuhgfea
Current NFT ID #450436 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
450436
Accession (UniProt):
A4W4F3
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Streptococcus suis (strain 98HAH33)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A4W4F3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A4W4F3|SYL_STRS2 Leucine--tRNA ligase OS=Streptococcus suis (strain 98HAH33) OX=391296 GN=leuS PE=3 SV=2 MSFYNHKEIEPKWQEFWAKNHTFKTGTDAEKPNFYALDMFPYPSGAGLHVGHPEGYTATDILSRYKRAQGYNVLHPMGWDAFGLPAEQYAMDTGNDPADFTAENIANFKRQINALGFSYDWDREVNTTDPNYYKWTQWIFTKLYEKGLAYEAEVPVNWVEELGTAIANEEVLPDGTSERGGYPVVRKPMRQWMLKITAYAERLLNDLEEVDWPESIKDMQRNWIGKSTGANVTFKIKDTDKDFTVFTTRPDTLFGATYAVLAPEHDLVDSITSAEQAEAVAEYKRQASLKSDLARTDLAKDKTGVWTGAYAINPVNGKEIPIWIADYVLASYGTGAIMAVPAHDERDWEFAKQFGLDIIPVLEGGNVEEAPYTEDGAHINSDFLDGLNKEEAIAKMVAWLEENGVGQEKISYRLRDWLFSRQRYWGEPIPIIHWEDGTSTAVPENELPLVLPKTSDIKPSGTGESPLANLTDWLEVVREDGVKGRRETNTMPQWAGSSWYYLRYIDPHNDEKLADEDLLKAWLPVDIYIGGAEHAVLHLLYARFWHKFLYDLGVVPTKEPFQKLFNQGMILGTSYRDSRGALVATDKVEKRDGSFFHMETGEELEQAPAKMSKSLKNVVNPDDVVEQFGADTLRVYEMFMGPLDASIAWSEEGLEGSRKFLDRVYRLLTTKELVAENSGALDKVYNETVKTVTEHIEDLKFNTAIAQLMIFVNAANKEDKLYVDYAKGFVQLIAPFAPHLAEELWQGLANTGQSISYVAWPTYDESKLVESEVEIVVQIKGKVKARLTVAKDLAPAELEKVALADEKVQAEIAGQTVVKVISVPNKLVNIVVK